1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ASXL3 CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA CIPC CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA EPHA10 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA ZCCHC2 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA RMND5A CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA SLC25A16 CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA ZBTB8B CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA TSR3 CTRPv2 pan-cancer AAC -0.13 5e-05
mRNA TMEM151B CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA FAM184B CTRPv2 pan-cancer AAC 0.14 5e-05
Download CSV